Experience in switching monoclonal antibodies in a patient with severe refractory atopic dermatitis: from Dupilumab to Abrocitinib. Case report . Revista Alergia México, [S. l.], v. 72, n. 4, p. 382–385, 2025. DOI: 10.29262/ram.v72i4.1547. Disponível em: https://www.revistaalergia.mx/ojs/index.php/ram/article/view/1547. Acesso em: 24 sep. 2026.